New method for the quantification of dequalinium cations in pharmaceutical samples by absorption and fluorescence diode array thin-layer chromatography.
A diode array HPTLC method for dequalinium chloride in pharmaceutical preparations is presented. For separation a Nano TLC silica gel plate (Merck) is used with the mobile phase methanol-7.8% aqueous NH(4)(+)CH(3)COO(-) (17:3, v/v) over a distance of 6 cm. Dequalinium chloride shows an R(F) value of 0.58. Pure dequalinium chloride is measured in the wavelength range from 200 to 500 nm and shows several by-products, contour plot visualized in absorption, fluorescence and using the Kubelka-Munk transformation. Scanning of a single track in absorption and fluorescence measuring 600 spectra in the range from 200 to 1100 nm takes 30s. As a sample pre-treatment of an ointment it is simply dissolved in methanol and can be quantified in absorption from 315 to 340 nm. The same separation can also be quantified using fluorescence spectrometry in the range from 355 to 370 nm. A new staining method for dequalinium chloride, using sodium tetraphenyl borate/HCl in water allows a fluorescence quantification in the range from 445 to 485 nm. The linearity range of absorption and fluorescence measurements is from 10 to 2000 ng. Sugar-containing preparations like liquids or lozenges with a reduced sample pre-treatment can be reliably quantified only in fluorescence. The total for the quantification of an ointment sample (measuring four standards and five samples), including all sample pre-treatment steps takes less than 45 min!
Hiegel
Katharina
K
University of Offenburg, Institute of Process Engineering, Offenburg, Germany.
Spangenberg
Bernd
B
D000042:Absorption; D002138:Calibration; D002412:Cations / Q000032:analysis; D002855:Chromatography, Thin Layer / Q000379:methods*; D003868:Dequalinium / Q000031:analogs & derivatives / Q000032:analysis* / Q000592:standards; D004304:Dosage Forms / Q000592:standards; D005453:Fluorescence; D016014:Linear Models; D008956:Models, Chemical; D009824:Ointments / Q000737:chemistry; D019999:Pharmaceutical Solutions / Q000737:chemistry; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013775:Tetraphenylborate / Q000737:chemistry
D002412:Cations; D004304:Dosage Forms; D009824:Ointments; D019999:Pharmaceutical Solutions; D013775:Tetraphenylborate; D003868:Dequalinium